ANNE ZAJAC: Open Payments
NPI 1104804707 · BOARDMAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,829 in 93 payments from 22 companies in 2025. Trend: 2023 $1,803 · 2024 $2,372 · 2025 $1,829
Food & beverage: $1,829
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $525 |
| Janssen Biotech, Inc. | 22 | $314 |
| Galderma Laboratories, L.P. | 6 | $109 |
| GENZYME CORPORATION | 5 | $102 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| LEO Pharma Inc. | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 4 | $69 |
| Incyte Corporation | 3 | $65 |
| Amgen Inc. | 3 | $55 |
Products named: TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, NEMLUVIO, Sotyktu, OPZELURA, ANZUPGO.
Industry payments across OH — which companies pay providers there.
